Second trial of mesalamine therapy in the treatment of active Crohn's disease
- PMID: 8039647
- DOI: 10.1016/0016-5085(94)90210-0
Second trial of mesalamine therapy in the treatment of active Crohn's disease
Comment on
-
Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group.Gastroenterology. 1993 May;104(5):1293-301. doi: 10.1016/0016-5085(93)90337-c. Gastroenterology. 1993. PMID: 8482443 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
